Document Information


PMID 16242643  (  )
Title Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death.
Abstract Experimental and clinical studies support the view that the semisynthetic tetracycline minocycline exhibits neuroprotective roles in several models of neurodegenerative diseases, including ischemia, Huntington, Parkinson diseases, and amyotrophic lateral sclerosis. However, recent evidence indicates that minocycline does not always present beneficial actions. For instance, in an in vivo model of Huntington's disease, it fails to afford protection after malonate intrastriatal injection. Moreover, it reverses the neuroprotective effect of creatine in nigrostriatal dopaminergic neurons. This apparent contradiction prompted us to analyze the effect of this antibiotic on malonate-induced cell death. We show that, in rat cerebellar granular cells, the succinate dehydrogenase inhibitor malonate induces cell death in a concentration-dependent manner. By using DFCA, monochlorobimane and 10-N-nonyl-Acridin Orange to measure, respectively, H2O2-derived oxidant species and reduced forms of GSH and cardiolipin, we observed that malonate induced reactive oxygen species (ROS) production to an extent that surpasses the antioxidant defense capacity of the cells, resulting in GSH depletion and cardiolipin oxidation. The pre-treatment for 4 h with minocycline (10-100 microM) did not present cytoprotective actions. Moreover, minocycline failed to block ROS production and to abrogate malonate-induced oxidation of GSH and cardiolipin. Additional experiments revealed that minocycline was also unsuccessful to prevent the mitochondrial swelling induced by malonate. Furthermore, malonate did not induce the expression of the iNOS, caspase-3, -8, and -9 genes which have been shown to be up-regulated in several models where minocycline resulted cytoprotective. In addition, malonate-induced down-regulation of the antiapoptotic gene Bcl-2 was not prevented by minocycline, controversially the mechanism previously proposed to explain minocycline protective action. These results suggest that the minocycline protection observed in several neurodegenerative disease models is selective, since it is absent from cultured cerebellar granular cells challenged with malonate. Castilla-La Mancha, Avda, Almansa, s/n, 02006 Albacete, Spain.

NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.



Targets by SciMiner Summary

HUGO ID Symbol Target Name #Occur ActualStr
990BCL2B-cell CLL/lymphoma 228Bcl-2 | bcl 2 |
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)13iNOS | nitric oxide synthase |
1504CASP3caspase 3, apoptosis-related cysteine peptidase10caspase 3 |
19986CYCScytochrome c, somatic3cytochrome c |
21528DIABLOdiablo homolog (Drosophila)2DIABLO | SMAC |
5992IL1Binterleukin 1, beta1interleukin 1 beta |
4141GAPDHglyceraldehyde-3-phosphate dehydrogenase1GAPDH |
399ALBalbumin1serum albumin |
11920FASFas (TNF receptor superfamily, member 6)1Fas |
8768AIFM1apoptosis-inducing factor, mitochondrion-associated, 11apoptosis inducing factor |

 


Targets by SciMiner Full list

HUGO ID Symbol Name ActualStr Score FlankingText
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5Furthermore malonate did not induce the expression of the iNOS caspase-3 -8 and -9 genes which have been shown to
990BCL2B-cell CLL/lymphoma 2Bcl-26.2In addition malonate-induced down-regulation of the antiapoptotic gene Bcl-2 was not prevented by minocycline controversially the mechanism previously proposed
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5expression of interleukin 1 beta inducible nitric oxide synthase (iNOS), iNOS caspase-3 and -1 ( Chen et al. 2000
21528DIABLOdiablo homolog (Drosophila)SMAC1.8turn inhibits the release of the proapoptotic factors cytochrome c SMAC (DIABLO) DIABLO and apoptosis-inducing factor from the mitochondria ( Wang
21528DIABLOdiablo homolog (Drosophila)DIABLO1.8the release of the proapoptotic factors cytochrome c SMAC (DIABLO) DIABLO and apoptosis-inducing factor from the mitochondria ( Wang et al.
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5no modifications in the expression of the mRNA's encoding for iNOS caspase-3 -8 and -9 after malonate additions were found we
4141GAPDHglyceraldehyde-3-phosphate dehydrogenaseGAPDH0.3(Cycle Cycle threshold method ( Livak and Schmittgen 2001 using GAPDH as internal control once demonstrated that the efficiency for the
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5iNOS caspase-3 -8 and -9 mRNA expression levels are not modulated
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5Among them the down-regulation of caspases and iNOS and the up-regulation of Bcl-2 have been documented recently (
990BCL2B-cell CLL/lymphoma 2Bcl-26.2the down-regulation of caspases and iNOS and the up-regulation of Bcl-2 have been documented recently ( Wang et al. 2004
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5cell death we first analyzed the pattern of expression of iNOS caspase-3 -8 and -9 and the antiapoptotic gene Bcl-2 in
990BCL2B-cell CLL/lymphoma 2Bcl-26.2of iNOS caspase-3 -8 and -9 and the antiapoptotic gene Bcl-2 in malonate-treated cells
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5in cell viability does not modify the expression of the iNOS caspase-3 -8 and -9 genes
990BCL2B-cell CLL/lymphoma 2Bcl-26.2mM malonate caused a significant down-regulation of the antiapoptotic gene Bcl-2 ( Fig 6 B
990BCL2B-cell CLL/lymphoma 2Bcl-26.2Therefore we studied whether minocycline would prevent the down-regulation of Bcl-2 gene expression induced by malonate
990BCL2B-cell CLL/lymphoma 2Bcl-26.2lack of protective effect failed to block the down-regulation of Bcl-2 caused by malonate
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5mRNA expression of caspase-3 -8 and -9 as well as iNOS it decreases the mRNA of the antiapoptotic protein Bcl-2 an
990BCL2B-cell CLL/lymphoma 2Bcl-26.2as iNOS it decreases the mRNA of the antiapoptotic protein Bcl-2 an effect that was not abrogated by minocycline
11920FASFas (TNF receptor superfamily, member 6)Fas0.3hydroperoxide phenylarsine oxide or non-oxidative (Ca/Pi, Ca Pi t-Bid Bid Fas mechanism ( Chu et al. 2005 Wang et al. 2003
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5be modulated by minocycline after different neurotoxic stimuli such as iNOS and several members of the caspase family ( Chen et
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5no changes in the expression of the genes coding for iNOS caspase-3 -8 and -9
990BCL2B-cell CLL/lymphoma 2Bcl-26.2Conversely we did find a significant down-regulation of Bcl-2 expression after a 24-h malonate exposure
990BCL2B-cell CLL/lymphoma 2Bcl-26.2It should be noted that the up-regulation of Bcl-2 gene expression has been recently proposed as a mechanism mediating
990BCL2B-cell CLL/lymphoma 2Bcl-26.2present work this drug failed to reverse the down-regulation of Bcl-2 induced by malonate treatment nor induced Bcl-2 expression by itself
990BCL2B-cell CLL/lymphoma 2Bcl-26.2the down-regulation of Bcl-2 induced by malonate treatment nor induced Bcl-2 expression by itself
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5Fig 6._amp_#xa0 Malonate does not affect iNOS caspase-3 -8 and -9 but significantly reduces Bcl-2 mRNA expression
990BCL2B-cell CLL/lymphoma 2Bcl-26.2not affect iNOS caspase-3 -8 and -9 but significantly reduces Bcl-2 mRNA expression levels mRNA expression in malonate-treated cerebellar granular cells
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)iNOS2.5(A) A Lack of effects of malonate on the iNOS caspase-3 -8 and -9 mRNA expression levels
990BCL2B-cell CLL/lymphoma 2Bcl-26.2(B) B Effect of malonate on Bcl-2 mRNA expression levels
990BCL2B-cell CLL/lymphoma 2Bcl-26.2Minocycline pre-treatment fails to avoid the Bcl-2 down-regulation induced by malonate
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0furthermore malonate did not induce the expression of the inos caspase 3 8 and 9 genes which have been shown to be up regulated in several models where minocycline resulted cytoprotective.
990BCL2B-cell CLL/lymphoma 2bcl 21.0in addition malonate induced down regulation of the antiapoptotic gene bcl 2 was not prevented by minocycline controversially the mechanism previously proposed to explain minocycline protective action.
5992IL1Binterleukin 1, betainterleukin 1 beta1.0in this sense tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 .
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 .
7873NOS2Anitric oxide synthase 2A (inducible, hepatocytes)nitric oxide synthase1.0in this sense tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 .
8768AIFM1apoptosis-inducing factor, mitochondrion-associated, 1apoptosis inducing factor1.0this blockade in turn inhibits the release of the proapoptotic factors cytochrome c smac diablo and apoptosis inducing factor from the mitochondria wang et al. 2003 and zhu et al. 2002 .
19986CYCScytochrome c, somaticcytochrome c1.0this blockade in turn inhibits the release of the proapoptotic factors cytochrome c smac diablo and apoptosis inducing factor from the mitochondria wang et al. 2003 and zhu et al. 2002 .
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0moreover although no modifications in the expression of the mrna's encoding for inos caspase 3 8 and 9 after malonate additions were found we observed a significant reduction of blc 2 mrna expression which was not reverted by minocycline.
399ALBalbuminserum albumin1.0tissues were incubated with trypsin for 20 min at 37_amp_#xb0;c and dissociated by trituration in a medium containing dnase bovine serum albumin and trypsin inhibitor.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0inos caspase 3 8 and 9 mrna expression levels are not modulated by malonate
990BCL2B-cell CLL/lymphoma 2bcl 21.0among them the down regulation of caspases and inos and the up regulation of bcl 2 have been documented recently wang et al. 2004 .
990BCL2B-cell CLL/lymphoma 2bcl 21.0in order to check whether these pathways were involved in malonate induced granular cell death we first analyzed the pattern of expression of inos caspase 3 8 and 9 and the antiapoptotic gene bcl 2 in malonate treated cells.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0in order to check whether these pathways were involved in malonate induced granular cell death we first analyzed the pattern of expression of inos caspase 3 8 and 9 and the antiapoptotic gene bcl 2 in malonate treated cells.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0the results shown in fig. 6 a revealed that malonate at the concentration which causes a significant decrease in cell viability does not modify the expression of the inos caspase 3 8 and 9 genes.
990BCL2B-cell CLL/lymphoma 2bcl 21.0however 50 mm malonate caused a significant down regulation of the antiapoptotic gene bcl 2 fig 6 b .
990BCL2B-cell CLL/lymphoma 2bcl 21.0therefore we studied whether minocycline would prevent the down regulation of bcl 2 gene expression induced by malonate.
990BCL2B-cell CLL/lymphoma 2bcl 21.0as depicted in fig. 6 b minocycline consistently with its lack of protective effect failed to block the down regulation of bcl 2 caused by malonate.
990BCL2B-cell CLL/lymphoma 2bcl 21.0additionally although malonate treatment fails to induce the mrna expression of caspase 3 8 and 9 as well as inos it decreases the mrna of the antiapoptotic protein bcl 2 an effect that was not abrogated by minocycline.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0additionally although malonate treatment fails to induce the mrna expression of caspase 3 8 and 9 as well as inos it decreases the mrna of the antiapoptotic protein bcl 2 an effect that was not abrogated by minocycline.
19986CYCScytochrome c, somaticcytochrome c1.0cardiolipin is a phospholipid located in the inner mitochondrial membrane whose oxidation can be the consequence of the release of cytochrome c from the mitochondria to the cytoplasm tuominen et al. 2002 a release that we have previously observed to be increased in sh sy5y cells challenged with malonate fern_amp_#xe1;ndez g_amp_#xf3;mez et a
19986CYCScytochrome c, somaticcytochrome c1.0as a consequence of permeability transition pore formation cytochrome c is released to the cytoplasm turning on the apoptotic machinery.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0we found no changes in the expression of the genes coding for inos caspase 3 8 and 9.
990BCL2B-cell CLL/lymphoma 2bcl 21.0conversely we did find a significant down regulation of bcl 2 expression after a 24 h malonate exposure.
990BCL2B-cell CLL/lymphoma 2bcl 21.0it should be noted that the up regulation of bcl 2 gene expression has been recently proposed as a mechanism mediating minocycline induced cytoprotection wang et al. 2004 .
990BCL2B-cell CLL/lymphoma 2bcl 21.0however abounding on the lack of protective effect by minocycline in the present work this drug failed to reverse the down regulation of bcl 2 induced by malonate treatment nor induced bcl 2 expression by itself.
990BCL2B-cell CLL/lymphoma 2bcl 21.0fig. 6._amp_#xa0;malonate does not affect inos caspase 3 8 and 9 but significantly reduces bcl 2 mrna expression levels. mrna expression in malonate treated cerebellar granular cells was quantitatively measured by real time pcr using gadph mrna levels as control.
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0fig. 6._amp_#xa0;malonate does not affect inos caspase 3 8 and 9 but significantly reduces bcl 2 mrna expression levels. mrna expression in malonate treated cerebellar granular cells was quantitatively measured by real time pcr using gadph mrna levels as c
1504CASP3caspase 3, apoptosis-related cysteine peptidasecaspase 31.0 a lack of effects of malonate on the inos caspase 3 8 and 9 mrna expression levels.
990BCL2B-cell CLL/lymphoma 2bcl 21.0 b effect of malonate on bcl 2 mrna expression levels.
990BCL2B-cell CLL/lymphoma 2bcl 21.0minocycline pre treatment fails to avoid the bcl 2 down regulation induced by malonate.
990BCL2B-cell CLL/lymphoma 2bcl 21.0cardiolipins|enzyme inhibitors|malonates|neuroprotective agents|neurotoxins|proto oncogene proteins c bcl 2|reactive oxygen species|minocycline|malonic acid|glutathione|succinate dehydrogenase|caspases|